Is Medicare Advantage really better?
A recent report from The Commonwealth Fund found that despite the belief that Medicare Advantage members are more satisfied with
Read More
Part D/Prescription Drugs
CMS Issues Additional Guidance on Program to Allow People with Medicare to Pay Out-of-Pocket Prescription Drug Costs in Monthly Payments
(Source – www.cms.gov) The Centers for Medicare & Medicaid Services (CMS) released the second part of draft guidance for the
Read MoreSenators to FDA: Take action on proliferation of social media drug ads
(By Erica Carbajal for Becker’s Hospital Review) Senators are urging the FDA to update decade-old guidance and take action to
Read MorePatients See First Savings From Biden’s Drug Price Push, as Pharma Lines Up Its Lawyers
(By Arthur Allen for KFF Health News) Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst,
Read MoreHumana sued over Medicare Advantage 340B payments
(By Rylee Wilson for Becker’s Hospital Review) Montgomery, Ala.-based Baptist Health is suing Humana, alleging the insurer’s Medicare Advantage plan
Read More3 Charts About Drug Prices in the United States
(By Craig Palosky for The Kaiser Family Foundation published February 7, 2024) Prescription drug costs are a top concern for
Read MoreIncome and Assets of Medicare Beneficiaries in 2023
(By Alex Cottrill, Juliette Cubanski, Tricia Neuman, and Karen Smith for The Kaiser Family Foundation Published: Feb 05, 2024) More
Read MoreAnother cancer injectable drug goes into shortage
(By Paige Twenter for Becker’s Hospital Review) Multiple solutions of etoposide, an injectable used for testicular and small cell lung
Read More3 Charts About Medicare Drug Price Negotiations
(Chris Lee for The Kaiser Family Foundation published January 31, 2024) Under the Inflation Reduction Act, the federal government for
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Jan 31, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More